Transaction DateRecipientSharesTypePriceValue
28th October 2020Michael M Tarnow10,288Bona fide gift$0.00
28th October 2020Michael M Tarnow5,144Exercise of derivative$3.76$19,341.44
28th October 2020Michael M Tarnow5,144Exercise of derivative$3.76$19,341.44
28th October 2020Gary Patou2,057Exercise of derivative$3.76$7,734.32
15th October 2020Michael R Hayden1,778Exercise of derivative$0.00
20th August 2020Simon N. Pimstone45,000Other acquisition or disposition$0.00
1st July 2020Michael R Hayden1,778Exercise of derivative$0.00
9th June 2020Michael M Tarnow5,144Exercise of derivative$3.52$18,106.88
1st June 2020Sherrington Robin1,630Payment by withholding$13.70$22,331.00
1st June 2020Sherrington Robin8,230Exercise of derivative$3.56$29,298.80
Xenon Pharmaceuticals
Xenon Pharmaceuticals logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.


Xenon Pharmaceuticals, Inc. focuses on the treatment of epilepsy. The company was founded by Simon Neil Pimstone, Johannes J. P. Kastelein, and Michael R. Hayden on November 5, 1996 and is headquartered in Burnaby, Canada.


Ticker: XENE
Sector: Health Technology
Industry: Biotechnology
SEC Central Index Key (CIK): 1582313
Employees: 104
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals
Cash at Carrying Value: $44 M (78%)
Marketable Securities, Current: $159 M (35%)
Assets, Current: $207 M (42%)
Property, Plant and Equipment, Net: $2 M (41%)
Assets: $211 M (42%)
Liabilities, Current: $21 M (-51%)
Liabilities: $21 M (-61%)
Common Stock, Value, Issued: $398 M (35%)
Common Stock, Shares, Issued: $35 M (24%)
Additional Paid in Capital, Common Stock: $42 M (3%)
Retained Earnings (Accumulated Deficit): $257 M (0%)
Accumulated Other Comprehensive Income (Loss), Net of Tax: $990 Th (0%)
Stockholders' Equity (Parent): $189 M (0%)
Liabilities and Equity: $211 M (42%)
Research and Development: $11 M (-52%)
General and Administrative Expenses: $3 M (-50%)
Operating Income/Loss: $646 Th (-92%)
Provision for income taxes: $39 Th (-2%)
EPS (basic): $0 (-100%)
EPS (diluted): $0 (-100%)